Pharmacy Costs: Can I Make a Difference?

Size: px
Start display at page:

Download "Pharmacy Costs: Can I Make a Difference?"

Transcription

1 Pharmacy Costs: Can I Make a Difference?

2 Pharmaceutical Market Dynamics What is driving Rx cost up? No New Blockbusters Patent Expirations OTC Market Dynamics Availability Pharmaceutical Companies Unfortunately, not all pharma company actions deliver value to the Health Care System. Increase utilization Drive preference Creative packaging New indications Price inflation Specialty drugs Frequent price increases New indications Patent extensions Slight modifications to: Dosage Delivery mechanism Dosage frequency Combination drugs Physicians Do not know Rx costs 80,000 Pharma Reps Sampling of brand drugs Employees Don t always know lower cost options Consuming $5 billion in pharma advertising Requests influence physician prescriptions Newer is better perception Employer Rx Cost Who is protecting your Rx investment?

3 2009 Generics The Calm Before the Storm $93.1 billion in Brand Drugs Off-Patent from : Risperdal, Lamictal, Fosamax, Imitrex 2009: Adderall, Prevacid, Topamax, Valtrex $ : Effexor XR, Flomax, Cozaar, Hyzaar $11.6 $18.5 $ : Lipitor, Actos, Protonix, Zyprexa, Levaquin, Aricept 2012: Plavix, Singulair, Seroquel, Lexapro, Diovan, Avandia $9.3 $6.5 $7.3 $ : Cymbalta, Celebrex, Aciphex 2014: Nexium, Vytorin, Zetia, Lyrica, Nasonex 2015: Abilify

4 Value Value = Outcome Cost

5 What is the # 1 diagnosis at ThedaCare?

6 Treatment of Hypertension Algorithm Source: JNC 7 (

7 Compelling Indications for Individual Drug Classes Compelling Indication Initial Therapy Options Heart Failure Postmyocardial infarction High CVD risk Diabetes Chronic kidney disease Recurrent stroke prevention THIAZ, BB, ACEI, ARB, ALDO ANT BB, ACEI, ALDO ANT THIAZ, BB, ACEI, CCB THIAZ, BB, ACEI, ARB, CCB ACEI, ARB THAIZ, ACEI THAIZ = thiazide diuretic; ACEI = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; BB = beta blocker; CCB = calcium channel blocker; ALDO ANT = aldosterone antagonist Source: JNC 7 (

8 Lifestyle Modification Recommendations Modification Recommendation Average SBP Reduction Range* Weight reduction DASH eating plan Maintain normal body weight (body mass index kg/m 2 ) Adapt a diet rich in fruits, vegetables, and lowfat dairy products with reduced content of saturated fat 5-20 mm Hg/10 kg 8-14 mm Hg Dietary sodium reduction Aerobic physical activity Reduce dietary sodium intake to <100 mmol (2.4 g sodium or 6 g sodium chloride) Regular aerobic physical activity (eg, brisk walking) at least 30 minutes per day, most days of the week 2-8 mm Hg 4-9 mm Hg Moderation of alcohol consumption Men: limit to <2 drinks t per day. Women and lighter-weight persons: limit to <1 drink t per day 2-4 mm Hg * Effects are dose and time dependent t 1 drink ½ oz or 15 ml ethanol (eg, 12 oz beer, 5 oz wine, 1.5 oz 80-proof whiskey) Source: JNC 7 (

9 Class: Angiotensin receptor blockers (ARBs) Diovan/Diovan HCT Opportunity Pharma Strategy Price inflation The prices for Diovan/Diovan HCT are expected to increase significantly after 1/1/09 Indication: Hypertension and heart failure Avg. ARB Cost Diovan Diovan will cost 86% more than other Tier 2 ARBs and 15% more than other Tier 3 ARBs. Benefit Patients: Mitigate the expected increased costs for these medications through incentives for higher value, lower cost choices Mitigates increased cost of Diovan and encourages lower cost equivalents

10 Half Tablet Program Can all pills be split? Is pill splitting for everyone? NO! Once a day dose Flat priced Same clinical outcomes Voluntary tell doctor

11 Top 3 opportunities for ½ tab program Blood Pressure Meds: ARBs Cholesterol Lowering: Lipitor/Crestor Antidepressants: Lexapro

12 Caduet Class: Lipid/Cholesterol Lowering Indication: Hypertension, High Cholesterol Opportunity Pharma Strategy Patent extension Combination of atorvastatin (Lipitor) and amlodipine (generic Norvasc). Priced at a premium to individual components. Clinical Assessment Caduet is therapeutically equivalent to atorvastatin and amlodipine taken separately. Lipitor $$ + Generic = Caduet Norvasc $$$$ $ Benefit Patients: Will not pay a high cost for Caduet when individual medications are available at a lower net cost. Patients: Same treatment results by taking individual components; can pay an even lower copayment by switching to another statin. Combination drug with no unique value

13 Class: Beta Blocker Indication: High Blood Pressure/Heart Failure Coreg CR Opportunity Pharma Strategy Patent extension Coreg CR is priced significantly more than generic Coreg. Clinical Assessment Coreg CR contains the same active ingredient as generic Coreg, but is taken once a day as opposed to twice a day. Generic Coreg $ = Taken twice daily Coreg CR $$$$ Taken once daily Benefit Patients: Will not pay a cost premium for a medication available at a lower cost Patients: Generic Coreg provides the same active ingredient at an affordable cost Me too drug with no added clinical value

14 Moderate LDL Reduction Lescol XL Pravachol (pravastatin) Mevacor (lovastatin) 25%-34% LDL reduction

15 Potent LDL Reduction Zocor (simvastatin) Lipitor Crestor 26%-63% LDL reduction

16 Clinical + Financial Decision $120/$30 $20/$10 copay copay Lipitor LDL reduction simvastatin 10 mg 39% 20 mg 20 mg 43% 40 mg 40 mg 50% 80 mg 80 mg 60%

17 Zetia 10 mg = 18 % $90 Cheerios = 5 % Oatmeal = 10 %

18 Vytorin Zetia 10 mg = 18% Zetia 5 mg = 16% #30 Vytorin 10/20 = 45% $90 #15 Vytorin 10/40 = 55% $45

19

20

21 Pharmacy Example (100 Prescriptions with 10 refills) Prescriber A simvastatin 40 mg 30 =$0 10 refills =$0 OTC Prilosec 20 mg 30 =$0 10 refills =$0 fluoxetine 20 mg 40 =$0 10 refills =$0 Total $0 Prescriber B Lipitor 20 mg 30 $100 =$3, refills =$30,000 Nexium 40 mg 30 $100 =$3, refills =$30,000 Cymbalta 60 mg 40 $100 =$4, refills =$40,000 Total $100,000

22 Questions/Comments?

Hypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program

Hypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program Hypertension: JNC-7 Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! Reference Card

More information

Table 1: Price increases for Brand Name Drugs with Generic Equivalents

Table 1: Price increases for Brand Name Drugs with Generic Equivalents Table 1: Price increases for Brand Name Drugs with Generic Equivalents Brand Name Medication and Dose Total % Change Since 10/2012 ACTOS 15 MG TABLET 6.36 11.03 73.39% ACTOS 30 MG TABLET 9.7 16.80 73.23%

More information

Pharmacy Trends and Management Opportunities. Kerry Bendel, R.Ph. Director of Pharmacy Medica

Pharmacy Trends and Management Opportunities. Kerry Bendel, R.Ph. Director of Pharmacy Medica Pharmacy Trends and Management Opportunities Kerry Bendel, R.Ph. Director of Pharmacy Medica September 14, 20 1 Agenda Pharmacy Trend Experience Trend Drivers and Management Opportunities Call to Action

More information

Daiichi Sankyo, Inc. (DSI)

Daiichi Sankyo, Inc. (DSI) Daiichi Sankyo, Inc. (DSI) Outlook for U.S. Business for 2009 Nov. 7 th, 2007 Joseph P. Pieroni President and CEO Daiichi Sankyo, Inc. Largest Pharmaceutical markets $300 $274.4 Annual Sales (US$ billions)

More information

Generics. Lead with. P r e s c r i p t i o n S t e p T h e r a p y P r o g r a m

Generics. Lead with. P r e s c r i p t i o n S t e p T h e r a p y P r o g r a m Lead with Generics P r e s c r i p t i o n S t e p T h e r a p y P r o g r a m WWW.BCBSLA.COM 04HQ3972 5/09 Blue Cross and Blue Shield of Louisiana incorporated as Louisiana Health Service & Indemnity

More information

Hypertension and the Challenge of Adherence. Geneva Clark Briggs, Pharm.D., BCPS

Hypertension and the Challenge of Adherence. Geneva Clark Briggs, Pharm.D., BCPS Hypertension and the Challenge of Adherence Geneva Clark Briggs, Pharm.D., BCPS Outline Brief overview of HTN and pharmacologic therapies Role of pharmacists in collaboration with patients and physicians

More information

Diversity and HTN: Approaches to optimal BP control in AfricanAmericans

Diversity and HTN: Approaches to optimal BP control in AfricanAmericans Diversity and HTN: Approaches to optimal BP control in AfricanAmericans Quinn Capers, IV, MD, FACC, FSCAI Assistant Professor of Medicine Associate Dean for Admissions Do Racial Differences Really Exist

More information

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,

More information

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July

More information

Cost Effectiveness Recommendations For Kentucky Retirement Systems MTM Plan 2011

Cost Effectiveness Recommendations For Kentucky Retirement Systems MTM Plan 2011 Medication Tier 2 options Tier 1 options Nexium- Tier 3 Aciphex Lansoprazole Omeprazole Pantoprazole Crestor- Tier 3 Lipitor Simvastatin Vytorin- Tier 3 Atacand- Tier 3 Avapro Benicar Cozaar Micardis Tevetan

More information

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B) Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed

More information

PDF created with pdffactory trial version

PDF created with pdffactory trial version We are using more prescription drugs than ever before to manage health conditions and prevent problems. And those drugs are more expensive than ever before. In 2003, prescription drug costs in the United

More information

Hypertension JNC 8 (2014)

Hypertension JNC 8 (2014) Hypertension JNC 8 (2014) Renewed: February 2018 Updated: February 2015 Comparison of Seventh Joint National Committee (JNC 7) vs. Eighth Joint National Committee (JNC 8) Hypertension Guidelines Methodology

More information

Medications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.

Medications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy. Medications Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy. What do I need to know about medications after my heart attack? When you

More information

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy Hypertension Update Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy Introduction 1/3 of US adults have HTN More prevalent in non-hispanic

More information

Medications for Treating Stroke

Medications for Treating Stroke Medications for Treating Stroke Subject Expert Sonny Kupniewski, PharmD, BCPS Swedish Medical Center Englewood, CO 2 Objectives Medications used to prevent stroke Prevention of strokes in patients with

More information

UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008

UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008 UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008 Promoting high quality, cost effective drug therapy throughout the Military Health System UF Decisions, May 07 Class FY05 rank, total $

More information

Simvastatin 40 mg equivalent

Simvastatin 40 mg equivalent Simvastatin 40 mg equivalent medications equivalent to Simvastatin is available on the Drugs.com website. Simvastatin (Zocor ): 10 mg : Equivalent Dosages - 3: Atorvastatin (Lipitor. 40 mg : Equivalent

More information

Physician/Clinic Collaborative Practice Agreement

Physician/Clinic Collaborative Practice Agreement Physician/Clinic Collaborative Practice Agreement Effective October 1, 2010, Connecticut Senate Bill 428 (PA 10-117) extends to all settings and medical conditions the opportunity for licensed pharmacists

More information

JPMorgan Investor Meeting

JPMorgan Investor Meeting David B. Snow, Jr. Chairman and CEO JoAnn A. Reed Senior Vice President, Finance and CFO Richard J. Rubino,, CPA Senior Vice President, Controller and CAO Robert S. Epstein, M.D., M.S. Senior Vice President,

More information

Strategies for Managing Hypertension

Strategies for Managing Hypertension Strategies for Managing Hypertension by Marsha K. Millonig, MBA, RPh President,Catalyst Enterprises, LLC E.L.F. Publications, Inc. is accredited by the Accreditation Council for Pharmacy Education as a

More information

RxBlue 2010 ST Criteria

RxBlue 2010 ST Criteria RxBlue 2010 ST Criteria ANTIDEPRESSANTS - SARAFEM... 10 FLUOXETINE HCL... 10 SARAFEM... 10 SELFEMRA... 10 ANTIDEPRESSANTS- SSRI, SNRI... 11 CELEXA... 11 CITALOPRAM... 11 CYMBALTA... 11 EFFEXOR XR... 11

More information

Generics. Lead with. Prescription Step Therapy Program

Generics. Lead with. Prescription Step Therapy Program Lead with Generics Prescription Step Therapy Program WWW.BCBSLA.COM 04HQ3972 R11/10 Blue Cross and Blue Shield of Louisiana incorporated as Louisiana Health Service & Indemnity Company GENERIC DRUGS: A

More information

Using the New Hypertension Guidelines

Using the New Hypertension Guidelines Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in

More information

Adult Blood Pressure Clinician Guide June 2018

Adult Blood Pressure Clinician Guide June 2018 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Adult Blood Pressure Clinician Guide June 2018 Adult Blood Pressure Clinician Guide June 2018 Introduction This Clinician Guide is based on the 2018

More information

Combination Therapy for Hypertension

Combination Therapy for Hypertension Combination Therapy for Hypertension Se-Joong Rim, MD Cardiology Division, Yonsei University College of Medicine, Seoul, Korea Goals of Therapy Reduce CVD and renal morbidity and mortality. Treat to BP

More information

The Weekly Mortar & Pestle

The Weekly Mortar & Pestle The Weekly Mortar & Pestle A Publication of Walgreens Health Initiatives February 7, 2008 A publication created especially for our clients and associates, delivering up-to-date information about brand-name

More information

Renal Disease through the Ages: From Childbearing years to Old Age. Dr Elizabeth Jarvis, Renal Physician, General Physician, Obstetric Physician.

Renal Disease through the Ages: From Childbearing years to Old Age. Dr Elizabeth Jarvis, Renal Physician, General Physician, Obstetric Physician. Renal Disease through the Ages: From Childbearing years to Old Age Dr Elizabeth Jarvis, Renal Physician, General Physician, Obstetric Physician. Learning Outcomes: Understand the presentation of renal

More information

Pravastatin conversion to atorvastatin

Pravastatin conversion to atorvastatin P ford residence southampton, ny Pravastatin conversion to atorvastatin Pravastatin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology

More information

Management of High Blood Pressure in Adults

Management of High Blood Pressure in Adults Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) James, P. A. (2014, February 05). 2014 Guideline for Management

More information

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI Hypertension, Hyperlipidemia and Obesity Mi-CCSI Objectives Review the prevalence of hypertension, hyperlipidemia and obesity Correlation of the 3 conditions Discuss why it is important to treat these

More information

STATIN UTILIZATION MANAGEMENT CRITERIA

STATIN UTILIZATION MANAGEMENT CRITERIA STATIN UTILIZATION MANAGEMENT CRITERIA DRUG CLASS: HMG Co-A Reductase Inhibitors & Combinations Agents which require prior review: Advicor (niacin extended-release/lovastatin) Crestor (rosuvastatin)(5mg,10mg,

More information

9/13/2017. Presented by UIC College of Nursing Jessy Thomas FNP, MSN, MPH. Introduction Background Management

9/13/2017. Presented by UIC College of Nursing Jessy Thomas FNP, MSN, MPH. Introduction Background Management Presented by UIC College of Nursing Jessy Thomas FNP, MSN, MPH Introduction Background Management 2 1. Provide a basic level of knowledge regarding hypertension and hyperlipidemia to care coordinators/

More information

Steps Against Recurrent Stroke (STARS)

Steps Against Recurrent Stroke (STARS) Steps Against Recurrent Stroke (STARS) Take steps against recurrent stroke by making the necessary changes in your life. Your Guide to Ischemic Stroke What happened to me? You had a stroke. The stroke

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have

More information

Blood Pressure Treatment in 2018

Blood Pressure Treatment in 2018 Blood Pressure Treatment in 2018 Jay D. Geoghagan, MD, FACC Disclosures: None 1 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management

More information

Have you been paying for your prescription drugs? Stop!

Have you been paying for your prescription drugs? Stop! Dear Valued Medtipster Member: Have you been paying for your prescription drugs? Stop! Free prescription drugs are NOW just a Medtipster ID card away. Follow the steps below to obtain thousands of generic

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or

More information

Hypertension Pharmacotherapy: A Practical Approach

Hypertension Pharmacotherapy: A Practical Approach Hypertension Pharmacotherapy: A Practical Approach Ronald Victor, MD Burns & Allen Chair in Cardiology Director, The Hypertension Center Associate Director, The Heart Institute Hypertension Center 1. 2.

More information

Steps Against Recurrent Stroke (STARS)

Steps Against Recurrent Stroke (STARS) Steps Against Recurrent Stroke (STARS) Take steps against recurrent stroke by making the necessary changes in your life Your Guide to Ischemic What Happened to Me? You had a stroke. The stroke you had

More information

Diseases & Conditions

Diseases & Conditions http://my.clevelandclinic.org Diseases & Conditions About Cholesterol-Lowering Drugs Some people have a genetic predisposition to high blood cholesterol levels. These people may need drug therapy in addition

More information

Medications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy

Medications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy Medications for Type 2 Diabetes CDE Exam Preparation Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy Competency for CDE Exam 3.1.A Oral Medications for Type 2 Diabetes

More information

Clinical Recommendations: Patients with Periodontitis

Clinical Recommendations: Patients with Periodontitis The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;

More information

Hypertension (JNC-8)

Hypertension (JNC-8) Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint

More information

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series Our speaker today is: Susan Vos, BSN, RN, CCM Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series We will be starting shortly A few housekeeping items: We will be

More information

Anthem Prescription Management s Clinical Connections Program

Anthem Prescription Management s Clinical Connections Program Anthem Prescription Management s Clinical Connections Program Anthem Prescription is committed to helping you manage your health care benefits. Prior Authorization, Quantity Limits and are edits recommended

More information

AGGRENOX. Products Affected. Details. GRP B2 Last Updated: 09/01/2018. Aggrenox

AGGRENOX. Products Affected. Details. GRP B2 Last Updated: 09/01/2018. Aggrenox GRP B2 Last Updated: 09/01/2018 AGGRENOX Aggrenox A documented trial of one month of formulary generic aspirin/dipyridamole capsules. NR_0009_3742 09/2014 Formulary ID: 18066: version 15 1 ANTICONVULSANTS

More information

Understanding Your Patient Care Opportunity Report (PCOR)

Understanding Your Patient Care Opportunity Report (PCOR) Understanding Your Patient Care Opportunity Report (PCOR) Use your January/February 208 PCOR to help improve performance on Medicare Part D Clinical Star Ratings measures. Your January/February 208 Patient

More information

Quality ID #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease National Quality Strategy Domain: Effective Clinical Care

Quality ID #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease National Quality Strategy Domain: Effective Clinical Care Quality ID #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

Evaluating statin drugs to treat: High Cholesterol and Heart Disease Comparing Effectiveness, Safety, and Price

Evaluating statin drugs to treat: High Cholesterol and Heart Disease Comparing Effectiveness, Safety, and Price Evaluating statin drugs to treat: High Cholesterol and Heart Disease Comparing Effectiveness, Safety, and Price Contents Our Recommendations........................................... 3 Welcome....................................................

More information

Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011)

Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011) Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011) What s new in hypertension? NICE has issued an updated Clinical

More information

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing Hypertension and Hyperlipidemia University of Illinois at Chicago College of Nursing 1 Learning Objectives 1. Provide a basic level of knowledge regarding hypertension and hyperlipidemia and care coordinators/

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Caduet) Reference Number: CP.CPA.237 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy

More information

DEPARTMENT OF GENERAL MEDICINE WELCOMES

DEPARTMENT OF GENERAL MEDICINE WELCOMES DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global

More information

Prescription Drugs. Medicare & Medicaid Briefings National Health Policy Forum February 22, Jim Hahn Congressional Research Service

Prescription Drugs. Medicare & Medicaid Briefings National Health Policy Forum February 22, Jim Hahn Congressional Research Service Prescription Drugs Medicare & Medicaid Briefings National Health Policy Forum February 22, 2007 Jim Hahn Congressional Research Service Global and US. Prescription Drug Sales, 1998-2005 $700 $600 559 602

More information

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation

More information

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,

More information

ADVANCES IN MANAGEMENT OF HYPERTENSION

ADVANCES IN MANAGEMENT OF HYPERTENSION Advances in Management of Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Prevalence 29%; Blacks 33.5%

More information

Doctor discussion guide:

Doctor discussion guide: Doctor discussion guide: MAnaging Cholesterol Bring this printout to your next doctor s appointment. It will help you and your doctor work together to set goals for treatment, evaluate the success of your

More information

Long-Term Care Updates

Long-Term Care Updates Long-Term Care Updates August 2015 By Darren Hein, PharmD Hypertension is a clinical condition in which the force of blood pushing on the arteries is higher than normal. This increases the risk for heart

More information

C h a p t e r 1 7 JNC 7 Guidelines and Indian Scenario

C h a p t e r 1 7 JNC 7 Guidelines and Indian Scenario C h a p t e r 1 7 JNC 7 Guidelines and Indian Scenario M Paul Anand Consultant Physician, Lady Ratan Tata Medical Centre, M. Karve Road, Cooperage, Mumbai Executive Editor, API Textbook of Medicine Introduction

More information

Your cholesterol levels. Questions or concerns

Your cholesterol levels. Questions or concerns Because you have high cholesterol you should: Know your cholesterol levels Take the medicine to lower cholesterol that your doctor has told you to take Follow your doctor s treatment plan Keep your appointments

More information

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group Primary and Secondary Prevention of Cardiovascular Disease Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group AHA Diet and Lifestyle Recommendations Balance calorie intake and physical activity to

More information

Doctor discussion guide:

Doctor discussion guide: Bring this printout to your next doctor s appointment. It will help you and your doctor work together to set goals for treatment, evaluate the success of your treatment, and reduce your risk of side effects.

More information

Management of Hypertension. Ahmed El Hawary MD Suez Canal University

Management of Hypertension. Ahmed El Hawary MD Suez Canal University Management of Hypertension Ahmed El Hawary MD Suez Canal University Minimal vs. Optimal Care Resources more than science affect type of care and level of management. what is possible (minimal care) and

More information

Steps Against Recurrent Stroke (STARS)

Steps Against Recurrent Stroke (STARS) Steps Against Recurrent Stroke (STARS) Take steps against recurrent stroke by making the necessary changes in your life. Your Guide to Ischemic What happened to me? You had a stroke. The stroke you had

More information

CONCORD INTERNAL MEDICINE HYPERTENSION PROTOCOL

CONCORD INTERNAL MEDICINE HYPERTENSION PROTOCOL CONCORD INTERNAL MEDICINE HYPERTENSION PROTOCOL Douglas G. Kelling Jr., MD Carmella Gismondi-Eagan, MD, FACP George C. Monroe, III, MD Revised, April 8, 2012 The information contained in this protocol

More information

Six strategies to identify and assist patients burdened by out-of-pocket prescription costs

Six strategies to identify and assist patients burdened by out-of-pocket prescription costs REVIEW CME CREDIT G. CALEB ALEXANDER, MD, MS Robert Wood Johnson Clinical Scholars Program, MacLean Center for Clinical Medical Ethics, University of Chicago, Chicago, IL CHIEN-WEN TSENG, MD, MPH Pacific

More information

Pharmaceutical Help to Control Cholesterol

Pharmaceutical Help to Control Cholesterol Pharmaceutical Help to Control Cholesterol Catherine E. Cooke, PharmD, BCPS, PAHM President, PosiHealth, Inc. Clinical Associate Professor, Univ. of Maryland This program has been brought to you by PharmCon

More information

Hypertension Management Controversies in the Elderly Patient

Hypertension Management Controversies in the Elderly Patient Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No

More information

Safe, effective, affordable drug choices: online tool for payers and patients.

Safe, effective, affordable drug choices: online tool for payers and patients. Executive summary: Rising healthcare costs and greater access to medical information drive patients to seek options for their drug therapy. The MedAlternatives database by Gold Standard/Elsevier empowers

More information

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Management of Lipid Disorders and Hypertension Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine

More information

AGGRENOX. Products Affected. Details. First Health Part D Value Plus (PDP) Last Updated: 10/01/2017. Aggrenox

AGGRENOX. Products Affected. Details. First Health Part D Value Plus (PDP) Last Updated: 10/01/2017. Aggrenox First Health Part D Value Plus (PDP) Last Updated: 10/01/2017 AGGRENOX Aggrenox A documented trial of one month of formulary generic aspirin/dipyridamole capsules. NR_0009_3742 09/2014 Formulary ID: 18059:

More information

Layered Approaches to Studying Drug Responses

Layered Approaches to Studying Drug Responses Layered Approaches to Studying Drug Responses Brian B Hoffman, MD Chief of Medicine VA Boston Health Care System Professor of Medicine Harvard Medical School Conflict of Interest: US Federal Grant Funding

More information

CHOLESTEROL REDUCING MEDICATIONS. Five Main Categories. 1. Statins 2. Fibrates 3. Resins 4. Niacin 5. Cholesterol absorption inhibitor

CHOLESTEROL REDUCING MEDICATIONS. Five Main Categories. 1. Statins 2. Fibrates 3. Resins 4. Niacin 5. Cholesterol absorption inhibitor Page 1 of 5 PHA-GEN-002-2004 CHOLESTEROL REDUCING MEDICATIONS Five Main Categories 1. Statins 2. Fibrates 3. Resins 4. Niacin 5. Cholesterol absorption inhibitor Statins Also called HMG-CoA reductase inhibitors

More information

ADVANCES IN MANAGEMENT OF HYPERTENSION

ADVANCES IN MANAGEMENT OF HYPERTENSION Prevalence 29%; Blacks 33.5% About 72.5% treated; 53.5% uncontrolled (>140/90) Risk for poor control: Latinos, Blacks, age 18-44 and 80,

More information

Copyright 2013 by Janet Brill All rights reserved. Published in the United States by Three Rivers Press, an imprint of the Crown Publishing Group, a

Copyright 2013 by Janet Brill All rights reserved. Published in the United States by Three Rivers Press, an imprint of the Crown Publishing Group, a Copyright 2013 by Janet Brill All rights reserved. Published in the United States by Three Rivers Press, an imprint of the Crown Publishing Group, a division of Random House, Inc., New York. www.crownpublishing.com

More information

Pharmacy benefit guide

Pharmacy benefit guide FlexRx SM 5-Tier Pharmacy benefit guide 1 Welcome to FlexRx The NHP FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many common medications

More information

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC HypertensionTreatment Guidelines Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC Objectives: Review the definition of the different stages of HTN. Review the current guidelines for treatment of HTN. Provided

More information

Get Healthy Stay Healthy

Get Healthy Stay Healthy Hypertension Management WHAT IS HYPERTENSION (HIGH BLOOD PRESSURE)? Blood pressure is a measure of how hard the blood pushes against the walls of your arteries as it moves through your body. It is normal

More information

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None Dr Narender Goel MD (Internal Medicine and Nephrology) drnarendergoel@gmail.com Financial Disclosure: None, Conflict of Interest: None 12 th December 2013, New York Visit us at: http://kidneyscience.info/

More information

New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets

New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets Sidney C. Smith, Jr. MD, FACC, FAHA Professor of Medicine/Cardiology University of

More information

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Disclosure No relevant

More information

Information in these slides is used with permission from St. Mary s Cardiac Rehab

Information in these slides is used with permission from St. Mary s Cardiac Rehab Information in these slides is used with permission from St. Mary s Cardiac Rehab Prescription Pointers Heart Medications Questions!! 2-4% of patients who visit ER s have experienced a medication misadventure

More information

Cholesterol. Medicines To Help You

Cholesterol. Medicines To Help You Medicines To Help You Cholesterol Use this guide to help you talk to your doctor, pharmacist, or nurse about your cholesterol medicines. The guide lists all of the FDA-approved products now available to

More information

Don t let the pressure get to you:

Don t let the pressure get to you: Balanced information for better care Don t let the pressure get to you: An update on the changing recommendations for treating hypertension New trial data and guidelines have made hypertension care more

More information

Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH)

Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH) Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH) Sidney C. Smith, Jr. MD, FACC, FAHA, FESC Professor of Medicine/Cardiology University of North Carolina

More information

Hypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic

Hypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic Hypertension in 2015: SPRINT-ing ahead of JNC-8 MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic Conflits of interest? None Disclaimer The opinions contained herein are not to be considered

More information

STEP THERAPY ALGORITHMS PUP Select Formulary

STEP THERAPY ALGORITHMS PUP Select Formulary The Step Therapy drug will be dispensed if the drug has been dispensed within 120 days of current fill or if alternative (Step 1) drugs have been used first. If the member s prescription claim fails the

More information

Conversion of crestor to lipitor

Conversion of crestor to lipitor Conversion of crestor to lipitor Apr 25, 2018. Atorvastatin (Lipitor ): 10 mg, Fluvastatin (Lescol ): 80 mg, Rosuvastatin. Nov 16, 2011. In a head-to-head test of two popular cholesterol-lowering statin

More information

Essays on the Economics of Drug Prescribing and Utilization. Mariana Patricia Carrera

Essays on the Economics of Drug Prescribing and Utilization. Mariana Patricia Carrera Essays on the Economics of Drug Prescribing and Utilization by Mariana Patricia Carrera A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Economics

More information

Achieving a Culture of Employee Health and Wellness

Achieving a Culture of Employee Health and Wellness Achieving a Culture of Employee Health and Wellness Mauret Brinser Executive Director, New Hampshire American Heart Association Mauret.brinser@heart.org Key Accomplishments of the Last Decade Established

More information

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI

More information

TAKING LUVOX AND WELLBUTRIN TOGETHER

TAKING LUVOX AND WELLBUTRIN TOGETHER TAKING LUVOX AND WELLBUTRIN TOGETHER Taking Luvox And Wellbutrin Together Wellbutrin make you sleepy Wellbutrin and low white blood cells Wellbutrin used with lexapro Wellbutrin xl full effect Wellbutrin

More information

Int. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences

Int. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences Research Article JNC 8 versus JNC 7 Understanding the Evidences Anns Clara Joseph, Karthik MS, Sivasakthi R, Venkatanarayanan R, Sam Johnson Udaya Chander J* RVS College of Pharmaceutical Sciences, Coimbatore,

More information

Realized Savings from Generic Drugs in Upstate New York

Realized Savings from Generic Drugs in Upstate New York T H E F A C T S A B O U T Realized Savings from Generic Drugs in Upstate New York More Than $130 Million Saved in 2006 Compared With 2005 Finger Lakes Region Estimated generic savings: $29 million Generic

More information

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient

More information

TRENDS IN MANUFACTURER PRICES OF BRAND-NAME PRESCRIPTION DRUGS USED BY OLDER AMERICANS SECOND QUARTER 2006 UPDATE

TRENDS IN MANUFACTURER PRICES OF BRAND-NAME PRESCRIPTION DRUGS USED BY OLDER AMERICANS SECOND QUARTER 2006 UPDATE TRENDS IN MANUFACTURER PRICES OF BRAND-NAME PRESCRIPTION DRUGS USED BY OLDER AMERICANS SECOND QUARTER 2006 UPDATE INTRODUCTION This Data Digest reports on changes in manufacturer prescription drug prices

More information

HealthPartners Care Coordination Clinical Care Planning and Resource Guide HYPERTENSION

HealthPartners Care Coordination Clinical Care Planning and Resource Guide HYPERTENSION The following evidence based guideline was used in developing this clinical care guide: National Institute of Health (NIH) and Journal of the American Medical Association (JAMA). Documented Health Condition:

More information